Bicycle Therapeutics plc Soared
Bicycle Therapeutics plc (BCYC:NASDAQ) soared at $25.5, representing a gain of 28.5%. On Wed 13 Jan 21, BCYC:NASDAQ hit a New 2-Week Intraday High of $20.34. The stock appeared on our News Catalysts scanner on Tue 12 Jan 21 at 11:56 AM in the 'MISCELLANEOUS' category. From Wed 30 Dec 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Bicycle Therapeutics plc (BCYC:NASDAQ)
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.
Top 10 Gainers:
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 105.36%
- VCA Inc. (WOOF:NASDAQ), 63.33%
- 3D Systems Corporation (DDD:NYSE), 36.21%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 34.89%
- DPW Holdings, Inc. (DPW:NYSEMKT), 33.65%
- CPS Technologies Corporation (CPSH:NASDAQ), 32.98%
- Acacia Communications, Inc. (ACIA:NASDAQ), 31.45%
- AeroVironment, Inc. (AVAV:NASDAQ), 30.28%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 29.29%
- Bicycle Therapeutics plc (BCYC:NASDAQ), 28.46%